Metabolic consequences of the West African diaspora: Lessons from the thrifty gene

Journal of Laboratory and Clinical Medicine

Volumn 133, Issue 2, 1999, Pages 98-111

  Osei, Kwame ^a  

^a 485 McCampbell Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033082168     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90002-1     Document Type: Article

References (64)

1. 1. King H, Revers M. Global estimates for prevalence of diabetes and impaired glucose tolerance in adults. Diabetes Care 1993;16:157-77.
2. 2. Harris HI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population, aged 20-74. Diabetes 1987;36:523-4.
3. 3. Fujimoto WY, Leonotti DLM, Kinyon JL. Prevalence of diabetes mellitus and impaired glucose tolerance among second generation Japanese-American men. Diabetes 1987;36:721-9.
4. 4. O'Dea K, Trainides K, Hopper JL, Larjins RG. Impaired glucose tolerance, hyperinsulinemia and hypertiglyceridemia in Australians of aboriginal descent. Diabetes Care 1991;11:23-9.
5. 5. Zimmet PS, Sergeantson S, Dowse G, Finch C, Collins V. Diabetes mellitus and cardiovascular disease in developing populations: hunter-gather in the fast lane. In: Gracy M, Kretchmer N, Rossi E, editors. Sugars in nutrition. Nestle Nutrition workshop series (vol 25). New York: Verey/Raven Press; 1990. p. 197-212.
6. 6. Haffner S, Howard G, Savage P, Mayer Davis, Bergman RN, Mykinen I, et al. Insulin sensitivity and acute insulin responses in African Americans, non-Hispanic whites, and Hispanics with NIDDM: The Insulin Resistance and Atherosclerosis Study. Diabetes 1997;46:63-9.
7. 7. Haffner S, Howard G, Savage P, Mayer Davis, Bergman RN, Mykinen I, et al. Insulin sensitivity and acute insulin responses in African Americans, non-Hispanic whites, and Hispanics: The Insulin Resistance and Atherosclerosis Study. Diabetes 1996;45:742-8.
8. 8. Zimmet P, Whitehouse S, Kiss J. Ethnic variability in the plasma insulin responses to oral glucose responses to oral glucose challenge. Diabetes 1978;29:229-92.
9. 9. Neel JV. Diabetes mellitus: a thrifty genotype rendered detrimental by progress. Am J Hum Genet 1962;14:353-62.
10. 10. Cooper R. Diabetes and thrifty gene [letter to editor]. Lancet 1994;344:1684.
11. 11. Dowsee GK, Zimmet PZ, Finch CF, Collins VR. Decline in including of epidemic glucose intolerance in Nauruans: implications for the "thrifty genotype". Am J Epidemiol 1991;133:1093-104.
12. 12. Denne SC, Bretchel G, Johnson A, Liechty EA, Baron AD. Skeletal muscle proteolysis is reduced in noninsulin-dependent diabetes mellitus and is unaltered by euglycemic hyperinsulinemia and intensive insulin therapy. J Clin Endocrinol Metab 1995;50:2371-7.
13. 13. Hales CN, Barker DJP. Type 2 diabetes mellitus. The thrifty phenotype hypothesis. Diabetologia 1992;35:595-601.
14. 14. Swinburn BA. The thrifty genotype hypothesis: how does it look after 30 years? Diabetes Med 1996;13:695-9.
15. 15. Reaven GM. Hypothesis: muscle insulin resistance is "not so" thrifty genotype. Diabetologia 1998;41:482-4.
16. 16. Ozanne SE, Hales CN. Thrifty yes, genetic no. Diabetologia 1998;41:485-7.
17. 17. Lovejoy PE. The African diaspora: revisionist interpretation of ethnicity, culture and religion under slavery. Studies in the world history of slavery, abolition and emancipation. Lancet 1997;2:1-22.
18. 18. Cooper RS, Rotimi CN, Kaufman JJS, Owoaje EE, Frazer H, Cruickshank JK. Prevalence of NIDDM among populations of African diaspora. Diabetes Care 1997;20:343-7.
19. 19. Banergi MA, Lebovitz HE. Insulin sensitive and insulin resistant variants of NIDDM diabetes. 1989;38:784-92.
20. 20. Mbanya JC, Nbogang J, Salah JN, Minkoukou E, Balkou B. Prevalence of NIDDM and impaired glucose tolerance in a rural and urban study in Cameroon. Diabetologia 1997;40:824-9.
21. 21. Osei K, Schuster DP. Decreased insulin-mediated but not noninsulin dependent glucose disposal rates in glucose intolerance and type 2 diabetes in African (Ghanaian) immigrants. Am J Med Sci 1996;311:113-21.
22. 22. Osei K, Gaillard T, Schuster DP. Pathogenic mechanisms of impaired glucose tolerance and type II diabetes in African Americans: the significance of insulin secretion, insulin sensitivity and glucose effectiveness. Diabetes Care 1997;20:396-404.
23. 23. Ezenwaka CE, Akanji AO, Unwin N, Alberti KGMM. Are body mass index or insulin resistance independently associated with cardiovascular risk factors in non-diabetic elderly Nigerians? Diabetes Med 1996;13:874-81.
24. 24. Swai ABM, Lutale I, McLarty DG. Diabetes in tropical Africa. A prospective study. 1981-1967. Br Med J 1990;300:1130-6.
25. 25. McClarty DG, Pollit C, Swai ABM. Diabetes in Africa. Diabetes Med 1990;11:670-84.
26. 26. Osei K, Schuster D. Ethnic differences in secretion, sensitivity and hepatic extraction of insulin in black and white Americans. Diabetes Med 1994;11:755-62.
27. 27. Osei K, Cottrell DA. Minimal model analyses of insulin sensitivity and glucose dependent glucose disposal in black and white Americans: a study of persons at risk for type 2 diabetes. Euro J Clin Invest 1994;24:843-50.
28. 28. Osei K, Schuster D. Metabolic characteristics of African descendants: a comparative study of African Americans and Ghanaian immigrants using minimal model analysis. Diabetologia 1995;38:1103-9.
29. 29. Kambo PK, Hitman GA, Mohan V, Ramanachandran A, Snehalata C, Suresh S, et al. The genetic predisposition to fibrocalculus pancreatic diabetes. Diabetologia 1989;32:45-51.
30. 30. Mohan V, Snehalata C, Jayashree R, Ramanachandran A, Viswanathan M. Pancreatic beta cell function in tropical pancreatic diabetes. Metabolism 1983;32:1091-2.
31. 31. Abu-Bakare A, Taylor R, Gill GV, Alberti KGMM. Tropical or malnutrition-related diabetes: a real syndrome? Lancet 1986;1:1135-8.
32. 32. Osei K, Ezenwaka CE, Akanji AO, Adejuwon CA, O'Dorisio TM, et al. Serum insulin and glucose concentrations in people at risk for type 2 diabetes. A comparative study of African Americans and Nigerians. Diabetes Care 1990;16:1367-74.
33. 33. Ezenwaka CE, Akanji AO, Osei K, Adejuwon CA, O'Dorisio TM, Cottrell DA, et al. Glucose and insulin responses to intravenous glucose challenge in relatives of Nigerian patients with non-insulin dependent diabetes mellitus. Diabetes Res Clin Pract 1993;20:175-81.
34. 34. Cruickshank JK, Cooper J, Burnett M, MacDuff J, Drubra U. Ethnic differences in fasting C-peptide and in relation to glucose tolerance and blood pressure. Lancet 1991;339:842-7.
35. 35. Joffe HL, Panz VR, Wing JR, Raal FJ, Seftel HC. Pathogenesis of non-dependent diabetes in the black population of southern Africa. Lancet 1992;343:460-2.
36. 36. Wing JR, Panz VR, Joffe BJ, Seftel HC. Changes in glucose disposal and cellular insulin binding in obese black Southern African patients with type 2 diabetes before and after sulphonylurea therapy. Diabetes Med 1993;10:50-5.
37. 37. Reaven GM, Bernstein R, Davis B, Olefsky JM. Nonketotic diabetes mellitus, insulin deficiency or insulin resistance. Am J Med 1978;60:80-6.
38. 38. Robertson RP. Diabetes and insulin resistance: philosophy, science and multiplier hypothesis. J Lab Clin Med 1995;125:560-4.
39. 39. Osei K, Gaillard T, Schuster D, Amoah ABG, Owusu SK. Early metabolic parameters of type 2 diabetes in high risk Ghanaians and African Americans [abstract]. Diabetes 1998;47:323.
40. 40. Osei K, Gaillard T, Schuster D, Amoah ABG, Owusu SK. West African origin of type 2 diabetes in Ghanaians and African Americans [abstract]. Diabetes 1998;47:324.
41. 41. Reaven GM. Role of insulin resistance in human diseases. Diabetes 1988;37:1595-607.
42. 42. Bogardus C. The case for insulin resistance as a necessary and sufficient cause of type 2 diabetes mellitus. J Lab Clin Med 1995;125:556-8.
43. 43. Bao WW, Srinivasan SR, Valdez R, Greenland J, Wattingney WA, Berenson GS. Longitudinal changes in cardiovascular risk from childhood to young adulthood in offspring of parents with coronary artery disease. The Bogalusa Heart Study. JAMA 1997;278:1740-54.
44. 44. Liu K, Ruth KJ, Flack JM, Jones-Webb R, Burke G, Savage PJ, et al. Blood pressure in young blacks and whites: relevance of obesity and lifestyle factors in determining differences. Circulation 1996;93:60-6.
45. 45. Panz VR, Wing JR, Joffe BJ, Raal FJ, Seftel HC. Insulin receptor activity in nondiabetic and diabetic urbanized South African black women. Diabetes Care 1991;15:277-81.
46. 46. Keil JE, Sutherland SE, Knapp RG, Lackland DT, Gazes PC, Tyroler HA. Mortality rates and risk for coronary artery disease in black as compared with white men and women. N Engl J Med 1993;329:73-8.
47. 47. Gillum RF, Grant CT. Coronary heart disease in black populations. Risk factors. Am Heart J 1996;104:852-64.
48. 48. Cowie C, Howard BU, Harris MI. Serum lipoproteins in African Americans and whites with noninsulin-dependent diabetes in the US population. Circulation 1994;90:1185-91.
49. 49. Banergi MA, Lebovitz HE. Coronary artery disease risk profiles in black patients with noninsulin dependent diabetes mellitus. Paradoxic patterns. Am J Med 1991;91:51-8.
50. 50. Banergi MA, Lebowitz J, Chaiken R, Kral JG, Lebovitz HE. Relationship of visceral adipose tissue and glucose disposal is independent of sex in black NIDDM subjects. Am J Physiol 1997;273:425-32.
51. 51. Gaillard T, Schuster DP, Bossetti BM, Green PA, Osei K. The impact of socioeconomic status on cardiovascular risk factors in African Americans at high risk for type II diabetes. Implications for syndrome X. Diabetes Care 1997;20:745-52.
52. 52. Chatuverdi N, Jarrett J, Morrish N, Keen H, Fuller JH. Differences in mortality in African Caribbean and European people with non-insulin dependent diabetes mellitus. Results of 20 year follow up of a London cohort of multinational study. Br Med J 1996;313:848-52.
53. 53. Sumner AE, Kushner H, Tulenko TN, Faulkner B, Marsh JB. The relationship in African Americans of sex differences in insulin-mediated suppression if non-esterified fatty acid to sex differences in fasting triglyceride levels. Metabolism 1997;46:400-5.
54. 54. Nyarko A, Adubofour KF, Kpodonu J, Owusu S. Serum lipid and lipoprotein levels in Ghanaians with diabetes mellitus and hypertension. J Natl Med Assoc 1997;89:191-6.
55. 55. Leslie AD, Mayer-Davis EJ, Davis Schmidt MI, Brancati FI, Heuss G. Familial components of the multiple metabolic syndrome. The ARIC Study. Diabetologia 1997;40:963-70.
56. 57. Saad MF, Lillioja S, Nyomba B, et al. Racial differences in the relations between blood pressure and insulin resistance. N Engl J Med 1991;324:733-9.
57. 58. Osei K, Schuster DP. Effects of race and ethnicity on insulin sensitivity, blood pressure and heart rate in three ethnic populations. Comparative studies in African Americans, African immigrants (Ghanaians) and white Americans using ambulatory blood pressure monitoring. Am J Hypertens 1996;9:1157-64.
58. 59. Faulkner B, Hulman S, Kushner H. Gender differences in insulin stimulated glucose utilization among African Americans. Am J Hypertens 1994;7:948-52.
59. 60. Conway JM, Yanosky SZ, Hubbard VS. Visceral adipose tissue differences in black and white women. Am J Clin Nutr 1995;61:765-70.
60. 61. Lovejoy JC, Bretonne JA, Klemperer M, Tulley R. Abdominal fat distribution and metabolic risk factors of race. Metabolism 1996;45:1119-24.
61. 62. Albu JB, Murphy L, Frager DH, Johnson JA, Pi-Sunyer FX. Visceral fat and race dependant health risks in obese nondiabetic premenopausal women. Diabetes 1997;46:456-62.
62. 63. Dowling HJ, Pi-Sunyer FX. Race-dependent health risks of upper body obesity. Diabetes 1993;42:537-43.
63. 64. Albu J, Sgur M, Curi M, Murphy L, Heymsfield SB, Pi-Sunyer FX. Resting metabolic rate in obese, premenopausal black women. Am J Clin Nutr 1997;66:531-8.
64. 65. Schuster D, Osei K. Reduced resting energy expenditure in nondiabetic, healthy African Americans compared to whites [abstract]. Clin Res 1998;46:207A.